Katharina Weizsäcker

Katharina Weizsäcker is a prominent academic figure at Humboldt-Universität zu Berlin, where they contribute to the Obstetrics and Gynecology through intensive research in HIV/AIDS in pregnancy, maternal health interventions, perinatal outcomes, gestational diabetes, cervical intraepithelial neoplasia, infectious disease in obstetrics, global maternal healthcare, vaccine effectiveness in pregnancy. A representative example of their recent contribution is the study titled "Efficacy and safety of 2-drug regime dolutegravir/lamivudine in pregnancy and breastfeeding – clinical implications and perspectives", which offers critical insights into the dynamics of HIV/AIDS in pregnancy and maternal health interventions. Additional work such as "Safety of tenofovir during pregnancy: early growth outcomes and hematologic side effects in HIV-exposed uninfected infants" further demonstrates their commitment to advancing knowledge in this domain.